RCC an TCC Flashcards

1
Q

What is a tcc

A

Calyceys, ureter, bladder, urethra, all transitional cels. The commonest type of cancer is transitional celll carcinoma- can occur anywhere in the lining

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a RCC

A
Renal cell tumour - can be benign or malignant but most are malignancy. 
RCC though (malignant) is in body of kidney
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does rcc present?

A
Localised or advanced 
• Haematuria 
•Incidental finding on imaging
– e.g. ultrasound or CT undertaken for another reason 
•(Rare – a palpable mass) 

If advanced
•Large varicocele may be present (Right sided large varicoloured is suspicious - USS of scrotum - if there is a large varicoloured, should also do a scan or kidney)
•Pulmonary/tumour embolus
•Loss of weight/loss of appetite symptom from metastasis
•Hypercalcaemia (Paracrie effect - can present with nausea, vomiting abdominal pain )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does tcc present

A

Localised or advanced
• Haematuria
• Incidental finding on imaging
– e.g. ultrasound or CT undertaken for another reason

If advanced
• Loss of weight/loss of appetite/symptom of metastasis
• DVT
• Lymphoedema
May need scan to differentiate DVT and lymhoedeama

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How can haematuria b classified

A

Visible or non-visible

Non-visible:
- symptomatic or asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the differential diagnosis for haematuria

A
• Urological
– Cancer
• RCC 
• Bladder cancer (90% TCC) 
• Upper urinary tract TCC 
• Advanced prostate carcinoma
– Other
• Stones
• Infection
• Inflammation
• Benign prostatic hyperplasia
(large)

• Nephrological (Glomerular)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are patients with haematuria Investigated?

A
• History
– Smoking
– Occupation
– Painful or painless - Pain - look for infective or inflammatory causes. 
– Other LUTS
– Family history
• Examination
– BP
– Abdominal mass
– Varicocele
– Leg swelling
– Assess prostate by DRE (male)
• Size • Texture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the investigations

A

Radiology
-Ultrasound
? CT
US - renal tumours, obstruction , hydronephrosis.. only proceed to CT if abnormal

Endoscopy
-Flexible cystoscopy
Look inside the bladder. Better for picking up smaller tumours in bladder than US. Scope into urethra.

Urine

  • ? Culture & sensitivity
  • ? Cytology

Bloods (Already checked in primary care)
-FBC -U&E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Descrbe the histology of rcc

A

S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the epidemiology o rc

A

• 7th most common cancer in UK • 95% of all upper urinary tract tumours • Incidence and mortality are ↑ing • Mortality is projected to fall in the next decade • M:F 3:2 • White > non-white • 30% metastases on presentation • Aetiology
– Smoking (2x↑)
– Obesity
– Dialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How can cc spread

A

Prinepric spread -Local - going into fatarund kidney
Lymph node mets
INV spread to RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe localised RCC treatment

A

– Surveillance (Some slow growing ones hardly change in size - just surveillance. Eg 4-5mm in 5y. Low risk of mets.)
– Excision
• Radical nephrectomy (Removal of kidney, adrenal, surrounding fat, upper ureter) - Open or Laparoscopic
• Partial nephrectomy - Open ofetn with Robotic assistance
– Ablation (Energy, eg microwave, freezing)
• Cryoablation
• Radiofrequency ablation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Desribe the metastatic rcc treatment

A

• Palliative
– Biological therapies
• Targeted therapies
– Those targeting angiogenesis are now 1st choice
» e.g Sunitinib, sorafenib, pazopanib
-ib (tyrosine kinase inhibitor) in this case VEGF. -ab (monoclonal antibody)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the epidemiology of bladder tcc

A

• In UK, 8th most common cancer in men, 14th in women • Incidence is ↓ing • But presentation is often more advanced in women • Mortality is ↓ing but less so in women
• M:F 3:1 • White > non-white • Risk factors
– Smoking 4x ↑
– Occupational exposure (20 yr latent period)
• Rubber or plastics manufacture (Arylamines) • Handling of carbon, crude oil, combustion, smelting (Polyaromatic
hydrocarbons) • Painters, mechanics, printers, hairdressers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Desribe the initial definitive treatment of bladder tcc

A

TUR bladder tumour (TURBT)
•Superficial TURBT
•Separate deep TUR of muscle
•Single intravesical instillation of mitomycin C
Cutting with electric cutters - trying to get it flush with bladder wall. Chemo but not systemic.local side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the staging of tc

A

Ss

17
Q

Describe the histological grading f tcc

A

S

18
Q

Describe further treatment foblader tcc

A

Lower risk non muscle-invasive TCC Muscle-invasive TCC (G1/G2/Ta)
Check cystoscopies +/- intravesicle chemotherapy

High risk non muscle-invasive TCC (G3/Tis/T1) •Check cystoscopies
•Intravesical immunotherapy
Having t helper 1 and t1 cytokines is what you wat for cnacers

Muscle-invasive TCC
Neoadjuvant chemotherapy
+ radical cystetomy of radiotherapy

19
Q

Describe teh treatment of muscle-invasive bladder tcc

A

S

20
Q

Describe radial cystectomy for bladder tcc

A

S

21
Q

Describe the epidemiology for upper urinary tract tcc

A

• Only 5% of all malignancies of upper urinary tract • Aetiology
– Smoking
– Phenacetin abuse
– Balkan’s nephropathy

22
Q

Descirbe the initial investigations of sustepcting uut tcc

A

• Ultrasound
– Hydronephrosis

• CT Urogram
– Filling defect
– Ureteric stricture

• Retrograde pyelogram

• Ureteroscopy
– Biopsy
– Washings for cytology
- to confirm suspicion

23
Q

What is the treatment of upper tract tcc

A

• Nephro-ureterectomy

kidney, fat, ureter, cuff of bladder

24
Q

Describe the treatment of metastatic tcc

A

• Systemic chemotherapy (Traditional)
– Cisplatin-based (need reasonable kidney function)

• Biological therapies
– Immunotherapy (New)
• Cancer cells employ a protective mechanism to avoid destruction by the immune system
– One anti-TCC strategy is to introduce antibodies to block this protective mechanism
» Targeting the Programmed Cell Death Receptor 1 (can be given in
the presence of poor renal function)
E.g. Atezolizumab; Pembrolizumab